Loading...
Repligen Q1 2025 Earnings Report
Repligen reported its financial results for the first quarter of 2025, showing growth in revenue and adjusted operating income.
Key Takeaways
Repligen had a strong start to 2025 with $169 million in revenue, representing 14% organic non-COVID growth, and a significant increase in adjusted operating income. Total orders grew nearly 20%, with all four franchises growing double-digits.
Revenue increased 10% year-over-year as reported, and 14% organically excluding COVID-related growth.
Orders grew sequentially and by high-teens year-over-year, indicating strong business momentum.
Adjusted operating income saw a substantial increase of 72% year-over-year.
The company reiterated its full-year 2025 organic revenue guidance of 9.5% - 13.5%.
Repligen
Repligen
Repligen Revenue by Segment
Revenue by Segment
Product Revenue
CapyFin.comRoyalty and Other Revenue
CapyFin.com Forward Guidance
Repligen's financial guidance for fiscal year 2025 is based on expectations for its existing business, excluding potential acquisitions, tariffs, and foreign currency fluctuations. The guidance incorporates the impact of the 908 Devices' Bioprocessing Analytics business acquisition.
Positive Outlook
- Reiterated strong organic revenue growth guidance of 9.5% - 13.5% for the full year.
- Anticipated adjusted operating income between $95 million and $102 million.
- Expected adjusted EBITDA margin between 19.5% and 20.5%.
- Projected adjusted net income between $92 million and $97 million.
- Forecasted adjusted earnings per share (diluted) between $1.63 and $1.72.
Challenges Ahead
- The guidance excludes the impact of any potential future business acquisitions.
- The guidance does not account for future fluctuations in foreign currency exchange rates.
- The guidance does not include the impact of tariffs.
- The acquisition of 908 Devices' bioprocessing portfolio is expected to result in a $4 million reduction in income from operations.
- A 100-basis point increase in gross margin is primarily due to a shift in costs from cost of goods sold to operating expenses, not an underlying improvement in profitability.
Revenue & Expenses
Visualization of income flow from segment revenue to net income